Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2022 | The importance of raising awareness and early diagnosis in amyloidosis

Scarlett McNally • 3 Apr 2022
BSH 2022
Amyloidosis Multiple Myeloma Rare Diseases

Scarlett McNally, BSc, MB, BChir, FRCS(Tr&Orth), MA, MBA, FAcadMed, East Sussex Healthcare NHS Trust, Sussex, UK, discusses the importance of early diagnosis in amyloidosis from a patient perspective. Dr McNally explains that raising awareness of amyloidosis and improving technologies are allowing patients to be diagnosed earlier, which results in improved outcomes for patients. This interview took place at the 62nd Annual Scientific Meeting of the British Society for Haematology (BSH) 2022, in Manchester, UK.

More from Scarlett McNally

2:42
An overview of patient-related factors from a surgeon's perspective
Scarlett McNally • 3 Apr 2022
2:30
Myeloma and amyloidosis: patient experience as a medical professional
Scarlett McNally • 3 Apr 2022

Related Videos

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals